Breaking News Instant updates and real-time market news.

BMY

Bristol-Myers

$56.91

0.61 (1.08%)

07:19
08/09/17
08/09
07:19
08/09/17
07:19

Bristol-Myers nivolumab granted orphan designation as treatment of anal cancer

Bristol-Myers' nivolumab was granted FDA orphan designation as treatment of anal cancer, according to a post to the agency's website. Reference Link

  • 11

    Sep

  • 24

    Sep

  • 09

    Nov

  • 05

    Mar

BMY Bristol-Myers
$56.91

0.61 (1.08%)

07/28/17
LEER
07/28/17
NO CHANGE
Target $61
LEER
Outperform
Bristol-Myers price target lowered to $61 after Astra trial setback at Leerink
Leerink analyst Seamus Fernandez said Bristol-Myers (BMY) reported "solid" Q2 results, including encouraging growth for its key franchises, but he sees increased uncertainty following the failure of AstraZeneca's (AZN) MYSTIC trial, which has potential read through to Bristol's CheckMate-227 trial of its I/O combo of Opdivo + Yervoy. Fernandez lowered his price target on Bristol shares to $61 from $66, but "fully acknowledges" the range of differences in the trial designs. He keeps an Outperform rating on Bristol-Myers, citing prospects for monotherapy Opdivo approval in the second-line setting and success in first-line liver cancer.
07/31/17
JANY
07/31/17
NO CHANGE
Target $107
JANY
Buy
Clovis partnership undercuts takeover thesis, says Janney Capital
Janney Capital analyst Debjit Chattopadhyay says Clovis Oncology's (CLVS) clinical partnership with Bristol-Myer Squibb (BMY) undercuts his takeout thesis. The recent agreements across the PARP drugs implies no near-term takeovers, Chattopadhyay tells investors in a research note. He believes this will "likely to be disappointing to many." The analyst has a Buy rating on Clovis with a $107 price target. The shares in early trading are down $8.04, or 8% to $89.97.
07/31/17
LEER
07/31/17
NO CHANGE
LEER
Outperform
Clovis weakness unwarranted after Bristol-Myers pact, says Leerink
Leerink analyst Michael Schmidt thinks today's weakness in Clovis (CLVS) is unwarranted following the company's clinical collaboration agreement with Bristol-Myers (BMY) and presents a buying opportunity. This deal does not preclude a future acquisition of the company, but it does increase the competitiveness and value of Rubraca, argues Schmidt, who reiterates his Outperform rating on Clovis shares.
08/08/17
GSCO
08/08/17
NO CHANGE
GSCO
Bristol-Myers stock could be worth $64-$74 per share, says Goldman Sachs
Goldman Sachs analyst Jami Rubin believes that Bristol-Myers could be worth $64-$74 per share ,depending on the outcome of a trial of its CM-227 cancer treatment. The analyst notes that if the trial is successful, the company will have the only IO treatment that works in conjunction with the CTLA-4 protein receptor, and Rubin says this will be "particularly meaningful"if patients taking CM-227 show.a higher overall survival rate than those taking chom combos. Rubin thinks the stock could be worth $59-$75 per share in a takeover with no value for CM-227, and the analyst says that at $50 per share the stock is reflecting no value for the company's first line NSCLC treatment. Rubin keeps the stock on the Americas Buy List.

TODAY'S FREE FLY STORIES

PZZA

Papa John's

$51.43

-2.04 (-3.82%)

17:41
07/16/18
07/16
17:41
07/16/18
17:41
Periodicals
Papa John's founder regrets stepping down as chairman, Bloomberg says »

Papa John's founder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

GLD

SPDR Gold Trust

$117.55

-0.045 (-0.04%)

17:36
07/16/18
07/16
17:36
07/16/18
17:36
Hot Stocks
SPDR Gold Trust holdings fall to 794.01MT from 795.19MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAXR

Maxar Technologies

$51.87

-1.06 (-2.00%)

17:29
07/16/18
07/16
17:29
07/16/18
17:29
Hot Stocks
Maxar's MDA acquires Neptec Design Group for C$42M »

MDA, a Maxar Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADSK

Autodesk

$136.21

-0.99 (-0.72%)

17:29
07/16/18
07/16
17:29
07/16/18
17:29
Syndicate
Breaking Syndicate news story on Autodesk »

Autodesk files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBS

CBS

$58.83

-0.18 (-0.31%)

17:28
07/16/18
07/16
17:28
07/16/18
17:28
Hot Stocks
Showtime: Cohen did not present self as disabled veteran in 'Who is America?' »

CBS' Showtime…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

  • 09

    Aug

  • 06

    Sep

KTOV

Kitov Pharmaceuticals

$2.22

-0.13 (-5.53%)

17:27
07/16/18
07/16
17:27
07/16/18
17:27
Syndicate
Kitov Pharmaceuticals files to sell 2.56M American Depositary Shares »

Each representing 20…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,822.02

9.02 (0.50%)

17:22
07/16/18
07/16
17:22
07/16/18
17:22
Hot Stocks
Amazon says 'some customers are having difficulty shopping' on Prime Day »

In a posting to its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 26

    Jul

  • 16

    Aug

FAF

First American

$51.89

0.02 (0.04%)

, FNF

Fidelity National

$37.23

0.14 (0.38%)

17:21
07/16/18
07/16
17:21
07/16/18
17:21
Upgrade
First American, Fidelity National rating change  »

First American upgraded…

FAF

First American

$51.89

0.02 (0.04%)

FNF

Fidelity National

$37.23

0.14 (0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 26

    Jul

NAKD

Naked Brand Group

$4.95

-0.15 (-2.94%)

17:20
07/16/18
07/16
17:20
07/16/18
17:20
Syndicate
Breaking Syndicate news story on Naked Brand Group »

Naked Brand Group files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FNF

Fidelity National

$37.23

0.14 (0.38%)

17:20
07/16/18
07/16
17:20
07/16/18
17:20
Upgrade
Fidelity National rating change  »

Fidelity National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

LMT

Lockheed Martin

$319.13

0.69 (0.22%)

17:20
07/16/18
07/16
17:20
07/16/18
17:20
Hot Stocks
Lockheed Martin awarded $450.7M U.S. Navy contract modification »

Lockheed Martin awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

FDEF

First Defiance Financial

$33.61

1.005 (3.08%)

17:18
07/16/18
07/16
17:18
07/16/18
17:18
Earnings
First Defiance Financial reports Q2 adjusted EPS 54c, consensus 52c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 31

    Jul

LNT

Alliant Energy

$42.79

-0.14 (-0.33%)

17:05
07/16/18
07/16
17:05
07/16/18
17:05
Hot Stocks
Alliant Energy announces 210MW wind farm in Iowa »

Iowa customers and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Aug

TRQ

Turquoise Hill

$2.94

0.11 (3.89%)

17:02
07/16/18
07/16
17:02
07/16/18
17:02
Hot Stocks
Turquoise Hill reports Q2 throughput production up 6.3% from Q1 »

Turquoise Hill Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVEO

Aveo Pharmaceuticals

$2.85

-0.055 (-1.90%)

17:02
07/16/18
07/16
17:02
07/16/18
17:02
Syndicate
Breaking Syndicate news story on Aveo Pharmaceuticals »

Aveo Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:55
07/16/18
07/16
16:55
07/16/18
16:55
Conference/Events
Morgan Stanleey econo »

Australian Economist…

RIG

Transocean

$13.10

-0.37 (-2.75%)

16:42
07/16/18
07/16
16:42
07/16/18
16:42
Hot Stocks
Transocean announces $75M 13-well contract for Transocean 712 »

Transocean announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

AG

First Majestic

$7.44

-0.265 (-3.44%)

16:40
07/16/18
07/16
16:40
07/16/18
16:40
Hot Stocks
First Majestic raises 2018 CapEx view to $148.7M from $125.4M »

First Majestic has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALLY

Ally Financial

$27.24

-0.09 (-0.33%)

16:39
07/16/18
07/16
16:39
07/16/18
16:39
Hot Stocks
Ally Financial raises quarterly dividend to 15c from 13c per share »

Payable on August 15 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 08

    Aug

OSG

Overseas Shipholding

$3.51

-0.125 (-3.44%)

16:38
07/16/18
07/16
16:38
07/16/18
16:38
Hot Stocks
Overseas Shipholding signs contract with HMD for two chemical tankers »

Overseas Shipholding…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AG

First Majestic

$7.44

-0.265 (-3.44%)

16:38
07/16/18
07/16
16:38
07/16/18
16:38
Hot Stocks
First Majestic reports Q2 production 5.1M Ag eq oz., raises 2018 guidance »

First Majestic reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHDN

Churchill Downs

$303.50

0.05 (0.02%)

16:35
07/16/18
07/16
16:35
07/16/18
16:35
Hot Stocks
Churchill Downs to acquire remaining 50% ownership of Ocean Downs »

Churchill Downs, or CDI,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

BAC

Bank of America

$29.77

1.235 (4.33%)

, DB

Deutsche Bank

$12.14

0.9 (8.01%)

16:33
07/16/18
07/16
16:33
07/16/18
16:33
General news
Fly Intel: Wall Street's top stories for Monday »

Stocks drifted throughout…

BAC

Bank of America

$29.77

1.235 (4.33%)

DB

Deutsche Bank

$12.14

0.9 (8.01%)

TRCO

Tribune Media

$32.05

-6.55 (-16.97%)

SBGI

Sinclair Broadcast

$29.10

-3.9 (-11.82%)

BHC

Bausch Health

$23.01

-0.39 (-1.67%)

VRX

Valeant

$0.00

(0.00%)

ARNC

Arconic

$19.19

1.8 (10.35%)

APO

Apollo Global

$35.90

-0.23 (-0.64%)

AMD

AMD

$16.58

0.305 (1.87%)

OSUR

OraSure

$16.28

-1.04 (-6.00%)

NTLA

Intellia Therapeutics

$29.37

-3.23 (-9.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Jul

  • 18

    Jul

  • 02

    Aug

  • 08

    Aug

  • 08

    Aug

  • 27

    Aug

  • 06

    Sep

NVCN

Neovasc

$0.04

-0.0004 (-1.05%)

16:33
07/16/18
07/16
16:33
07/16/18
16:33
Hot Stocks
Nasdaq schedules hearing to consider Neovasc's appeal of delisting »

Neovasc announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IGT

International Game

$24.39

-0.5 (-2.01%)

16:32
07/16/18
07/16
16:32
07/16/18
16:32
Hot Stocks
International Game announces FanDuel sports betting agreement »

International Game…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.